Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05589818
Title Pembrolizumab for Advanced NSCLC and PS 2-3
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Icahn School of Medicine at Mount Sinai
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST